Literature DB >> 32047085

Concurrent Guillain-Barré syndrome and myositis complicating dengue fever.

Manisha Gulia1, Preeti Dalal1, Monica Gupta2, Daljinderjit Kaur1.   

Abstract

Dengue is an arboviral infection that classically presents with fever, headache, joint pain, skin flush and morbilliform rashes. Neurological manifestations are well recognised but their exact incidence is unknown. Though myalgias are common in dengue virus infection, myositis and/or elevated serum creatine kinase is an uncommon complication. Guillain-Barré syndrome is another rare neurological manifestation associated with dengue fever. Here, we report the case of a 21-year-old man with serologically confirmed dengue fever presenting with severe myalgia, bilateral lower and upper limb weakness with raised creatine kinase, MRI suggestive of myositis and myonecrosis and nerve conduction velocity showing bilateral lower limb and axillary sensory motor neuropathy. He was managed conservatively and made an uneventful recovery. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  infection (neurology); infectious diseases; muscle disease; peripheral nerve disease

Mesh:

Substances:

Year:  2020        PMID: 32047085      PMCID: PMC7035824          DOI: 10.1136/bcr-2019-232940

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Atypical manifestations of dengue.

Authors:  Sameer Gulati; Anu Maheshwari
Journal:  Trop Med Int Health       Date:  2007-09       Impact factor: 2.622

Review 2.  Guillain-Barré syndrome.

Authors:  A F Hahn
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

3.  Neurological manifestations of dengue infection.

Authors:  T Solomon; N M Dung; D W Vaughn; R Kneen; L T Thao; B Raengsakulrach; H T Loan; N P Day; J Farrar; K S Myint; M J Warrell; W S James; A Nisalak; N J White
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

4.  Acute dengue virus myositis: a report of seven patients of varying clinical severity including two cases with severe fulminant myositis.

Authors:  Vimal Kumar Paliwal; Ravindra Kumar Garg; Ratish Juyal; Nuzhat Husain; Ritu Verma; Pawan Kumar Sharma; Rajesh Verma; Maneesh Kumar Singh
Journal:  J Neurol Sci       Date:  2010-11-16       Impact factor: 3.181

5.  Comparison of four reverse transcription-polymerase chain reaction procedures for the detection of dengue virus in clinical specimens.

Authors:  Boonyos Raengsakulrach; Ananda Nisalak; Niwat Maneekarn; Pa-Thai Yenchitsomanus; Chandhana Limsomwong; Aroonroong Jairungsri; Vipa Thirawuth; Sharone Green; Siripen Kalayanarooj; Saroj Suntayakorn; Nopporn Sittisombut; Prida Malasit; David Vaughn
Journal:  J Virol Methods       Date:  2002-09       Impact factor: 2.014

6.  Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells.

Authors:  Rajas V Warke; Aniuska Becerra; Agatha Zawadzka; Diane J Schmidt; Katherine J Martin; Kris Giaya; Jonathan H Dinsmore; Marcia Woda; Gregory Hendricks; Tracy Levine; Alan L Rothman; Irene Bosch
Journal:  J Gen Virol       Date:  2008-07       Impact factor: 3.891

Review 7.  Neurological complications of dengue virus infection.

Authors:  Francisco Javier Carod-Artal; Ole Wichmann; Jeremy Farrar; Joaquim Gascón
Journal:  Lancet Neurol       Date:  2013-09       Impact factor: 44.182

8.  Heart and skeletal muscle are targets of dengue virus infection.

Authors:  Doris Martha Salgado; José Miguel Eltit; Keith Mansfield; César Panqueba; Dolly Castro; Martha Rocio Vega; Kris Xhaja; Diane Schmidt; Katherine J Martin; Paul D Allen; Jairo Antonio Rodriguez; Jonathan H Dinsmore; José Rafael López; Irene Bosch
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

9.  The global distribution and burden of dengue.

Authors:  Samir Bhatt; Peter W Gething; Oliver J Brady; Jane P Messina; Andrew W Farlow; Catherine L Moyes; John M Drake; John S Brownstein; Anne G Hoen; Osman Sankoh; Monica F Myers; Dylan B George; Thomas Jaenisch; G R William Wint; Cameron P Simmons; Thomas W Scott; Jeremy J Farrar; Simon I Hay
Journal:  Nature       Date:  2013-04-07       Impact factor: 49.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.